PROCESS FOR THE PREPARATION OF N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1,3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE
Title: PROCESS FOR THE PREPARATION OF N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRA- ZOLO[1,5-A][1,3,5]TRIAZIN-4-YLAMINO)-2-0XOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE (57) : The invention generally relates to an improved process for the preparation of N-((lR,2S,5R)-5-(tert-butylamino)-24...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Title: PROCESS FOR THE PREPARATION OF N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRA- ZOLO[1,5-A][1,3,5]TRIAZIN-4-YLAMINO)-2-0XOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE (57) : The invention generally relates to an improved process for the preparation of N-((lR,2S,5R)-5-(tert-butylamino)-24(S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2- oxopyrrolidin- 1 -yl)cyclohexyl)acetamide, as well as novel inteiinediates employed in the process, which may be useful for the treatment of cancer. N N N ( N H N O (12) INTERNATIONAL APPLICATION PUBLISHED (19) World Intellectual Property Organization International Bureau UNDER THE PATENT COOPERATION TREATY (PCT) vitivio VIII 00 los OH u oimIE (10) International Publication Number WO 2019/018592 A2 PCT (43) International Publication Date 24 January 2019 (24.01.2019) WIP0 I New Brunswick, New Jersey 08903 (US). GREEN, Rebec- ca A.; c/o Bristol-Myers Squibb Company, 1 Squibb Dri- ve, New Brunswick, New Jersey 08903 (US). HICKEY, Matthew R.; c/o Bristol-Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903 (US). KOPP, Nathaniel David; c/o Bristol-Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903 (US). LA CRUZ, Thomas E.; c/o Bristol-Myers Squibb Com- pany, 1 Squibb Drive, New Brunswick, New Jersey 08903 (US). LAUSER, Kathleen; c/o Bristol-Myers Squibb Com- pany, 1 Squibb Drive, New Brunswick, New Jersey 08903 (US). LEE, Hong Geun; Seoul National University, De- partment of Chemistry 503-620, 1 Gwanak-Ro Gwanak-Gu, Seoul 08826 (KR). LEAHY, David K.; 10 Ida Road, Mar- blehead, MA 01945 (US). LUO, Helen Y.; c/o Bristol-My- ers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903 (US). RAZLER, Thomas M.; c/o Bristol-Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903 (US). SAVAGE, Scott A.; c/o Bristol-Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903 (US). SFOUGGATAKIS, Chris; c/o Bristol-Myers Squibb Company, 1 Squibb Dri- ve, New Brunswick, New Jersey 08903 (US). SOUMEIL- LANT, Maxime C.D.; c/o Bristol-Myers Squibb Compa- ny, 1 Squibb Drive, New Brunswick, New Jersey 08903 (US). ZARETSKY, Serge; c/o Bristol-Myers Squibb Com- pany, 1 Squibb Drive, New Brunswick, New Jersey 08903 (US). ZHENG, Bin; c/o Bristol-Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903 (US). ZHU, Ye; 111 Clementi Road, #07-02, Singapore 129792 (SG). (74) Agent: KORSEN, Elliott et al.; Bristol-Myers Squibb Company, Route 206 & Prov |
---|